Richard Giroux Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 day, 8 hours ago
Richard Giroux has an estimated net worth of at least $14.2 million*, as of yesterday. They own 908,530 shares of MGTX stock. They have sold 230,000 shares of MGTX stock since 2021, for an estimated $2.4 million.
Richard Giroux $MGTX SEC Form 4 Insider Trading
Richard Giroux has filed a total of 9 insider trades in $MGTX since 2021. Their most recent trade was a sale of 56,000 shares, made on Jul 21, 2026. Their largest trade was a sale of 56,000 shares, made on Jul 21, 2026. We estimate that they now own 908,530 shares of $MGTX, worth an estimated $11.8 million.
Insider Trading at $MGTX
There have been a total of 37 insider trades reported at $MGTX since 2021, with 5.6 million shares purchased and 719,402 shares sold. The most active insider traders in $MGTX stock have been Richard Giroux, Alexandria Forbes, and Alexandria Forbes. The most recent trade was a sale of 56,000 shares reported by Richard Giroux (CFO & COO), made on Jul 21, 2026.
History of Insider Stock Trades by Richard Giroux
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
MGTX
|
Sale | 56,000 | Jul 21, 2026 | July 21, 2026, 9:12 p.m. |
|
MGTX
|
Sale | 56,000 | Apr 21, 2026 | April 22, 2026, 6:04 a.m. |
|
MGTX
|
Sale | 24,000 | Oct 21, 2025 | Oct. 21, 2025, 9:19 p.m. |
|
MGTX
|
Sale | 24,000 | Jul 22, 2025 | July 22, 2025, 9:01 p.m. |
|
MGTX
|
Sale | 24,000 | Apr 22, 2025 | April 22, 2025, 8:54 p.m. |
|
MGTX
|
Sale | 24,000 | Jan 21, 2025 | Jan. 21, 2025, 10:17 p.m. |
|
MGTX
|
Sale | 6,956 | Oct 20, 2021 | Oct. 20, 2021, 8 p.m. |
|
MGTX
|
Sale | 13,744 | Oct 20, 2021 | Oct. 20, 2021, 8 p.m. |
|
MGTX
|
Sale | 1,300 | Oct 19, 2021 | Oct. 20, 2021, 8 p.m. |
$MGTX Executives and Stock Owners with Insider Trades
-
Richard Giroux, CFO & COO
-
Alexandria Forbes, President and CEO
-
Alexandria Forbes, PRESIDENT & CEO
-
Stuart Naylor, Chief Development Officer
-
Robert K Zeldin, CHIEF MEDICAL OFFICER
-
Stuart Naylor, CHIEF SCI OFCR, OPHTHALMOLOGY
-
Robert J Wollin, GENERAL COUNSEL AND SECRETARY
-
Stuart Naylor, CHIEF DEV. OFFICER
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.